Ask Warren

Icure Pharmaceutical Incorporation

175250 · KOSDAQ · ₩175250 · 아이큐어

₩1,530▲ ₩159 (11.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩38B₩32B₩11B₩25B₩25B₩22B₩21B₩16B
Cost of sales₩32B₩29B₩12B₩24B₩24B₩19B₩20B₩13B
Gross profit₩5.4B₩3.5B−₩1.3B₩1B₩1.2B₩3.4B₩1.1B₩2.3B
Operating income₩2.4B₩208M−₩1.8B−₩3.3B−₩4.4B−₩2.4B−₩4.6B−₩4.4B
Net income₩2.3B−₩669M−₩18B−₩3.9B−₩9.8B−₩2.5B−₩16B₩22B
Net income to shareholders₩2.3B−₩556M−₩18B−₩3.7B−₩9.5B−₩2.3B−₩16B₩22B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩92B₩84B₩90B₩121B₩129B₩124B₩133B₩142B
Current assets₩36B₩28B₩34B₩41B₩50B₩45B₩55B₩49B
Cash and equivalents₩7.4B₩3.2B₩8.3B₩3.9B₩9.8B₩4.5B₩17B₩15B
Total liabilities₩66B₩60B₩66B₩76B₩81B₩66B₩72B₩66B
Current liabilities₩58B₩53B₩59B₩66B₩70B₩59B₩65B₩57B
Borrowings₩23B₩24B₩25B₩35B₩41B₩40B₩41B₩38B
Total equity₩26B₩24B₩24B₩45B₩48B₩58B₩61B₩76B
Shareholders' equity₩28B₩26B₩26B₩46B₩50B₩59B₩60B₩75B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩5.1B−₩4.2B−₩194M−₩3B₩3.8B−₩3.3B−₩1.7B−₩7B
Capital spending₩620M₩601M₩139M₩2.5B₩455M₩2B₩1.5B₩229M
Free cash flow₩4.5B−₩4.8B−₩334M−₩5.5B₩3.3B−₩5.3B−₩3.2B−₩7.3B

Consolidated where available. Amounts in won.

Also known as: Icure Pharmaceutical Incorporation / 아이큐어 / 175250 / KRX:175250

Source: KRX statistical information